Bekker, P., Keshav, S., Wei, Z., Ertl, L., Wang, Y., Lai, N., . . . Schall, T. (2007). Pharmacological inhibition of CCR9 is a novel approach in the treatment of inflammatory bowel disease.
Chicago Style (17th ed.) CitationBekker, P., S. Keshav, Z. Wei, L. Ertl, Y. Wang, N. Lai, J. Wright, S. Ungashe, and T. Schall. Pharmacological Inhibition of CCR9 Is a Novel Approach in the Treatment of Inflammatory Bowel Disease. 2007.
MLA引文Bekker, P., et al. Pharmacological Inhibition of CCR9 Is a Novel Approach in the Treatment of Inflammatory Bowel Disease. 2007.
警告:這些引文格式不一定是100%准確.